Top Gum Links Costco to a Higher Sales Run Rate and Moves the Test to 2027
The expected Costco launch and an H2 annualized sales pace above $145 million improve growth visibility. The question is how much of that pace converts into profit and cash after the U.S. acquisition.
Top Gum reported two signals that strengthen its U.S. growth story: a product for a strategic North American customer is expected to launch at Costco in the fourth quarter, and based on orders and customer forecasts, H2 activity reflects an annualized sales pace above $145 million. This is not a small marketing data point. In H2 2025, the company discussed an annualized pace of about $120 million, so the update points to another demand step-up. But as in prior coverage, the test does not end with revenue. After acquiring Island Abbey's U.S. activity, Top Gum needs to show that growth flows through production, inventory, receivables and cash, not only through a higher order pace.
Costco Is a Quality Signal, Not Full Certainty
Expected entry into Costco matters because it is a large retail channel with distribution power, pricing discipline and the ability to scale a successful product quickly. The company expects the launch to contribute several million dollars in 2026 and to become more material in 2027. That wording matters: the immediate contribution is limited, and 2027 is the year in which the true effect should appear.
Costco can increase volume, but it can also pressure price, service, inventory and availability. The issue is not only whether the product launches, but whether it converts into repeat orders and attractive margins. A large customer can be an asset, but also a source of dependence if too much growth concentrates in one channel.
Higher Pace, Balance Sheet Still Matters
Top Gum has already proven demand for its functional gummy products, and the U.S. acquisition is meant to deepen its ability to serve the American market. The new filing improves visibility because it is based on orders and customer forecasts, not only management ambition. Still, an annualized run rate is not recognized revenue and not collected cash.
The company must finance inventory, production, delivery timing and customer credit. The faster the pace rises, the greater the risk that growth consumes cash before it produces cash. This is especially relevant after the Island Abbey transaction, with acquired operations, contingent consideration and a broader U.S. operating platform.
What the Reports Need to Show
The update improves sales visibility, but does not close the profitability question. Upcoming reports need to show whether gross margin is preserved, whether inventory and receivables are controlled, and whether cash flow starts catching up with revenue. A run rate above $145 million can support a strong growth story, but only if it is not bought with lower margins or heavy working capital.
The positive point is that Top Gum is not only talking about potential: it points to a strategic customer, a major retail channel and a higher order pace. The cautious point is that the market will now measure it less by customer headlines and more by conversion into 2027 financials.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.